Skip to content

Clinical trials

Observational Hepatitis B, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Observational Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20101
20132
20143
20151
20172
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Enrolling by invitation1
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Bristol-Myers Squibb1
Hologic, Inc.1
Medical Procare PLLC1
NYU Langone Health1
Novartis Pharmaceuticals1
Precision BioSciences, Inc.1
University of Arkansas1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic14
Hepatitis B3
Carcinoma, Hepatocellular2
Hepatitis2
Hepatitis C2
Hepatitis C, Chronic2
Hepatitis, Chronic2
Liver Diseases2
DNA Virus Infections1
Digestive System Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.